Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,110
Views
12
CrossRef citations to date
0
Altmetric
Back Matter

Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection

Qiu-Zhong Pana Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China;b Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
Jing-Jing Zhaoa Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China;b Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
Chao-Pin Yanga Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China;b Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
Yu-Qing Zhouc Department of Pediatrics, Yuexiu District Children’s Hospital, Guangzhou, ChinaView further author information
,
Jun-Zhong Lind Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
Yan Tanga Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China;b Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
Jia-Mei Gua Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China;b Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
Qi-Jing Wangb Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
Yong-Qiang Lib Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
Jia Heb Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
Shi-Ping Chenb Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
Meng-Jia Songa Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China;b Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
Yue Huanga Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China;b Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
Jie-Ying Yanga Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China;b Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaView further author information
,
De-Sheng Wenga Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China;b Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaCorrespondence[email protected]
View further author information
&
Jian-Chuan Xiaa Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China;b Department of Biotherapy, Sun Yat-Sen University Cancer Center, Guangzhou, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 1752563 | Received 14 Nov 2019, Accepted 23 Mar 2020, Published online: 17 Apr 2020

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Subhadeep Das & Diptikanta Acharya. (2023) Immunological Assessment of Recent Immunotherapy for Colorectal Cancer. Immunological Investigations 52:8, pages 1065-1095.
Read now
Raquel S Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, Daniel M Borras, Jannes Govaerts, Stefan Naulaerts, Zwi N Berneman, Benoit Beuselinck, Kalijn F Bol, Jannie Borst, an Coosemans, Angeliki Datsi, Jitka Fučíková, Lisa Kinget, Bart Neyns, Gerty Schreibelt, Evelien Smits, Rüdiger V Sorg, Radek Spisek, Kris Thielemans, Sandra Tuyaerts, Steven De Vleeschouwer, I Jolanda M de Vries, Yanling Xiao & Abhishek D Garg. (2022) Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. OncoImmunology 11:1.
Read now

Articles from other publishers (10)

Celine Man Ying Li, Runhao Li, Paul Drew, Timothy Price, Eric Smith, Guy J. Maddern, Yoko Tomita & Kevin Fenix. (2024) Clinical application of cytokine-induced killer (CIK) cell therapy in colorectal cancer: Current strategies and future challenges. Cancer Treatment Reviews 122, pages 102665.
Crossref
Rishu Takimoto, Takashi Kamigaki, Hisao Ito, Masashi Saito, Ken Takizawa, Kenzo Soejima, Hiroyuki Yasuda, Keiko Ohgino, Hideki Terai, Katsuro Tomita, Miyabi Miura, Eishiro Mizukoshi, Tomoharu Miyashita, Yasunari Nakamoto, Katsuhiro Hayashi, Shinji Miwa, Masaaki Kitahara, Akihiko Takeuchi, Hiroaki Kimura, Takafumi Mochizuki, Hiroki Sugie, Ken-ichiro Seino, Tomonori Yamada, Syuhei Takeuchi, Kaori Makita, Keiko Naitoh, Kosei Yasumoto, Yoichiro Yoshida, Hiroyuki Inoue, Katsuhiro Kotake, Kihachi Ohshima, Shin-ei Noda, Masahiko Okamoto, Yuya Yoshimoto, Sachiko Okada, Hiroshi Ibe, Eri Oguma & Shigenori Goto. (2023) Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG). Cytotherapy 25:11, pages 1229-1235.
Crossref
Yesim Eralp & Utku Ates. (2023) Clinical Applications of Combined Immunotherapy Approaches in Gastrointestinal Cancer: A Case-Based Review. Vaccines 11:10, pages 1545.
Crossref
Mohammad Al Zein, Mona Boukhdoud, Hadi Shammaa, Hadi Mouslem, Lemir Majed El Ayoubi, Rabah Iratni, Khodr Issa, Maha Khachab, Hazem I. Assi, Amirhossein Sahebkar & Ali H. Eid. (2023) Immunotherapy and immunoevasion of colorectal cancer. Drug Discovery Today 28:9, pages 103669.
Crossref
Celine Man Ying Li, Yoko Tomita, Bimala Dhakal, Runhao Li, Jun Li, Paul Drew, Timothy Price, Eric Smith, Guy J Maddern & Kevin Aaron Fenix. (2023) Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis. Journal for ImmunoTherapy of Cancer 11:4, pages e006764.
Crossref
Xinyi Yang, Desheng Weng, Qiuzhong Pan, Tong Xiang, Chaopin Yang, Zhengrong Wu, Minxing Li, Songzuo Xie, Yan Tang, Jianchuan Xia & Jingjing Zhao. (2022) Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer. Frontiers in Immunology 13.
Crossref
Ensaf M. Al-Hujaily, Batla S. Al-Sowayan, Zeyad Alyousef, Shahab Uddin & Farah Alammari. (2022) Recruiting Immunity for the Fight against Colorectal Cancer: Current Status and Challenges. International Journal of Molecular Sciences 23:22, pages 13696.
Crossref
Farimah Fayyaz, Niloufar Yazdanpanah & Nima Rezaei. (2022) Cytokine-induced killer cells mediated pathways in the treatment of colorectal cancer. Cell Communication and Signaling 20:1.
Crossref
Cristina Aparicio, Marina Belver, Lucía Enríquez, Francisco Espeso, Lucía Núñez, Ana Sánchez, Miguel Ángel de la Fuente & Margarita González-Vallinas. (2021) Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells. International Journal of Molecular Sciences 22:21, pages 11781.
Crossref
Shuier Zheng, Fenglin Wang, Jin Huang, Yan Zhou, Quanjun Yang, Guowei Qian, Chenliang Zhou, Daliu Min, Lele Song & Zan Shen. (2021) Case Report: Sequential Chemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden. Frontiers in Endocrinology 12.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.